Respiratory outcomes of adrenergic beta-antagonists in patients undergoing tracheal extubation: a systematic review and meta-analysis of randomized controlled trials
Desfechos respiratórios de beta-antagonistas adrenérgicos em pacientes submetidos à extubação traqueal: uma revisão sistemática e meta-análise de ensaios clínicos randomizados
Lucas Cael Azevedo Ramos Bendaham, Altair Pereira de Melo Neto, Hilária Saugo Faria, André Richard da Silva Oliveira Filho, Carlos Henrique de Oliveira Ferreira, Marcela da Silva Kazitani Cunha, Victor Gonçalves Soares, Ocílio Ribeiro Gonçalves, Milene Vitória Sampaio Sobral, Mohamed Doma, Denis Maltz Grutcki, Fabrício Tavares Mendonça
Abstract
Background
Tracheal extubation after general anesthesia may cause hemodynamic and respiratory complications, with no established strategies to prevent them. We conducted a meta-analysis to evaluate the safety and efficacy of beta-blockers in patients undergoing tracheal extubation.
Methods
We searched the MEDLINE, EMBASE and CENTRAL databases for randomized controlled trials up to 2024 comparing beta-blockers to placebo in patients undergoing tracheal extubation. Primary outcome: cough intensity; secondary: bronchospasm, bucking, hypertension. Risk Ratios (RR) with 95% Confidence Intervals (95% CI) were computed. Leave-one-out sensitivity and meta-regression analyses were performed for outcomes with high heterogeneity.
Results
We included 31 randomized studies, comprising 1,803 patients, of whom 965 received beta-blockers. The risk of moderate/severe cough (RR = 0.21; 95% CI 0.13 to 0.34; p < 0.001; I² = 0%) and hypertension (RR = 0.28; 95% CI 0.13 to 0.58; p < 0.001; I² = 45%) was significantly lower in the beta-blockers group compared with the placebo group. There were no statistically significant differences between groups in the risk of bronchospasm (RR = 0.58; 95% CI 0.17 to 1.94; p = 0.375; I² = 0%) or bucking (RR = 0.47; 95% CI 0.20 to 1.13; p = 0.093; I² = 72%). Sensitivity analysis identified Mendonça (2023) as the main heterogeneity source in bucking.
Conclusion
Our study demonstrates that beta-blockers reduced moderate/severe cough and hypertension in patients undergoing tracheal extubation compared with placebo with no significant difference in the risk of bronchospasm and bucking. These findings suggest beta-blockers may be a valuable strategy for preventing peri-extubation hemodynamic instability and airway hyperresponsiveness.
Prospero register
CRD42024542103.
Keywords
Resumo
Introdução
A extubação traqueal após anestesia geral pode causar complicações hemodinâmicas e respiratórias, sem estratégias estabelecidas para preveni-las. Realizamos uma meta-análise para avaliar a segurança e a eficácia dos betabloqueadores em pacientes submetidos à extubação traqueal.
Métodos
Foram pesquisadas as bases de dados MEDLINE, EMBASE e CENTRAL por ensaios clínicos randomizados até 2024 que comparassem betabloquadores ao placebo em pacientes submetidos à extubação traqueal. Desfecho primário: intensidade da tosse; secundários: broncoespasmo, esforço de tosse (bucking), hipertensão. Calculamos Risco Relativo (RR) com intervalos de confiança de 95% (IC 95%). Foram realizadas análises de sensibilidade leave-one-out e meta-regressão para desfechos com alta heterogeneidade.
Resultados
Foram incluídos 31 estudos randomizados, totalizando 1.803 pacientes, dos quais 965 receberam betabloqueadores. O risco de tosse moderada/grave (RR = 0,21; IC 95% 0,13–0,34; p < 0,001; I² = 0%) e de hipertensão (RR = 0,28; IC 95% 0,13–0,58; p < 0,001; I² = 45%) foi significativamente menor no grupo betabloqueadores em comparação ao grupo placebo. Não houve diferenças estatisticamente significativas entre os grupos quanto ao risco de broncoespasmo (RR = 0,58; IC 95% 0,17–1,94; p = 0,375; I² = 0%) ou de bucking (RR = 0,47; IC 95% 0,20–1,13; p = 0,093; I² = 72%). A análise de sensibilidade identificou Mendonça (2023) como a principal fonte de heterogeneidade em bucking.
Conclusão
Nosso estudo demonstra que os betabloqueadores reduziram a tosse moderada/grave e a hipertensão em pacientes submetidos à extubação traqueal, em comparação ao placebo, sem diferença significativa no risco de broncoespasmo e bucking. Esses achados sugerem que os betabloqueadores podem ser uma estratégia valiosa para prevenir instabilidade hemodinâmica e hiper-responsividade das vias aéreas no período periextubação.
Registro Prospero
CRD42024542103.
Palavras-chave
Referências
1. Hu S, Li Y, Wang S, Xu S, Ju X, Ma L. Effects of intravenous infusion of lidocaine and dexmedetomidine on inhibiting cough during the tracheal extubation period after thyroid surgery. BMC Anesthesiol. 2019;19:66.
2. Yang SS, Wang NN, Postonogova T, et al. Intravenous lidocaine to prevent postoperative airway complications in adults: a systematic review and meta-analysis. Br J Anaesth. 2020;124:314−23.
3. Asai T, Koga K, Vaughan RS. Respiratory complications associated with tracheal intubation and extubation. Br J Anaesth. 1998;80:767−75.
4. Frutos-Vivar F, Esteban A, Apezteguia C, et al. Outcome of reintubated patients after scheduled extubation. J Crit Care. 2011;26:502−9.
5. Gonzalez RM, Bjerke RJ, Drobycki T, et al. Prevention of endotracheal tube-induced coughing during emergence from general anesthesia. Anesth Analg. 1994;79(4):792−5.
6. Lowrie A, Johnston PL, Fell D, Robinson SL. Cardiovascular and plasma catecholamine responses at tracheal extubation. Br J Anaesth. 1992;68:261−3.
7. Coriat P, Mundler O, Bousseau D. Response of left ventricular ejection fraction to recovery from general anesthesia: Measurement by gated radionuclide angiography. Anesth Analg. 1986;65:593−600.
8. Bosco F, Braz J. Beta-blockers in anesthesiology: clinical and pharmacological aspects. Rev Bras Anestesiol. 2001;51:431−47.
9. Hosseinzadeh H, Eydi M, Ghaffarlou M, Ghabili K, Golzari S. Esmolol: a unique beta-blocker in maintaining cardiovascular stability following neurosurgical procedures. Adv Pharm Bull. 2012;2:249−52.
10. Ahmed M, Muntasir HA, Hossain M, et al. Beta-blockers show inverse agonism to a novel constitutively active mutant of beta1-adrenoceptor. J Pharmacol Sci. 2006;102:167−72.
11. Prajwal Patel HS, Shashank MR, Shivaramu BT. Attenuation of Hemodynamic Response to Tracheal Extubation: A Comparative Study between Esmolol and Labetalol. Anesth Essays Res. 2018;12:180−5.
12. Mendonca FT, Barreto Filho JH, Hungria MBCS, Magalh Es TC. ¸ Efficacy of a single dose of esmolol to prevent extubationrelated complications during emergence from anesthesia: a randomized, double-blind, placebo-controlled trial. Braz J Anesthesiol. 2023;73:426−33.
13. Alkaya M, Saracoglu K, Pehlivan G, Eti Z, Gogus F. Effects of esmolol on the prevention of haemodynamic responses to tracheal extubation after craniotomy operations. Turk J Anaesthesiol Reanim. 2014;42:86−90.
14. Amar D, Shamoon H, Frishman WH, Lazar EJ, Salama MD. Effects of labetalol on perioperative stress markers and isoflurane requirements. Br J Anaesth. 1991;67:296−301.
15. Arar C, Colak A, Alagol A, et al. The use of esmolol and magnesium to prevent haemodynamic responses to extubation after coronary artery grafting. Eur J Anaesthesiol. 2007;24:826−31.
16. Chia Y, Chan M, Ko N, Liu K. Role of beta-blockade in anaesthesia and postoperative pain management after hysterectomy. Br J Anaesth. 2004;93:799−805.
17. Biswal D, Dash L, Panda J, Ludam R, Dalai H. Comparative evaluation of esmolol, nitroglycerine and diltiazem on attenuation of the cardiovascular responses to tracheal extubation: a doubleblind randomized study. Int J Acad Med Pharm. 2023;5:1533−40.
18. Elokda S, Elshamaa H. Effect of esmolol infusion on myocardial oxygen consumption during extubation and quality of recovery in elderly patients undergoing general anesthesia: randomized, double blinded, clinical trial. Egypt J Anaesth. 2015;31:135−42.
19. Ersin Y, Celik M, Besler MP, Devrim S, Ka ¸ sik ¸ ci T. Comparing the ¸ effects of esmolol and diltizem to depressing the haemodynamic response against tracheal extubation. Goztepe Tip Derg. 2005;20:193−6.
20. Felding M, Jakobsen C, Cold G, Davidsen B, Jensen K. The effect of metoprolol upon blood pressure, cerebral blood flow and oxygen consumption in patients subjected to craniotomy for cerebral tumours. Acta Anaesthesiol Scand. 1994;38:271−5.
21. Grillo P, Bruder N, Auquier P, Pellissier D, Gouin F. Esmolol blunts the cerebral blood flow velocity increase during emergence from anesthesia in neurosurgical patients. Anesth Analg. 2003;96:1145−9.
22. Hosseinzadeh H, Eidi M, Ghaffarlou M, Torabi E, Ghabili K, Golzari S. Comparison of remifentanil with esmolol to blunt the cardiovascular response to tracheal extubation in patients undergoing neurosurgical procedures for intracranial masses. J Pak Med Assoc. 2013;63:950−4.
23. Kawaguchi M, Kawaraguchi Y, Yamamoto Y, et al. Effects of landiolol on systemic and cerebral hemodynamics and recovery from anesthesia in patients undergoing craniotomy. J Anesth. 2010;24:503−10.
24. Kshama S, Shenoy L, Sinha S. Comparison of two doses of intravenous esmolol in attenuation of hemodynamic response to extubation in laparoscopic surgeries. Indian Anaesth Forum. 2022;23:125−30.
25. Kurian S, Evans R, Fernandes N, Sherry K. The effect of an infusion of esmolol on the incidence of myocardial ischaemia during tracheal extubation following coronary artery surgery. Anaesthesia. 2001;56:1163−8.
26. Lee SJ, Lee JN. The effect of perioperative esmolol infusion on the post-operative nausea, vomiting and pain after laparoscopic appendectomy. Korean J Anesthesiol. 2010;59:179−84.
27. Lim S, Chin N, Tai H, Wong M, Lin T. Prophylactic esmolol infusion for the control of cardiovascular responses to extubation after intracranial surgery. Ann Acad Med Singapore. 2000;29:447−51.
28. Maharjan S. Propranolol is effective in decreasing stress response due to airway manipulation and CO2 pneumoperitoneum in patients undergoing laparoscopic cholecystectomy. Kathmandu Univ Med J KUMJ. 2005;3:102−6.
29. Miyazaki M, Kadoi Y, Saito S. Effects of landiolol, a short-acting beta-1 blocker, on hemodynamic variables during emergence from anesthesia and tracheal extubation in elderly patients with and without hypertension. J Anesth. 2009;23:483−8.
30. Morais V, Sakata R, Huang A, Ferraro L. Randomized, doubleblind, placebo-controlled study of the analgesic effect of intraoperative esmolol for laparoscopic gastroplasty. Acta Cir Bras. 2020;35:e202000408.
31. Nam D, Park B, Kang H. Cardiovascular Response of Esmolol and Diltiazem to Endotracheal Extubation. Korean J Anesthesiol. 1996;31:43−8.
32. O’Dwyer J, Yorukoglu D, Harris M. The use of esmolol to attenuate the haemodynamic response when extubating patients following cardiac surgery ‒ a double-blind controlled study. Eur Heart J. 1993;14:701−4.
33. de Queiroz M, Mendonca F, de Matos M, Lino R, de Carvalho L. Metoprolol for prevention of bucking at orotracheal extubation: a double-blind, placebo-controlled randomised trial. Braz J Anesthesiol. 2024;74:744455.
34. Radwan TAM, Fadel NA, Fahmy RS, Mustafa MY. Dexmedetomidine versus labetalol infusions for controlling emergence hypertension in cranial surgeries for supratentorial tumors. Egypt J Anaesth. 2016;32:463−72.
35. Shetabi H, Nazemroaya B, Mahjobipoor H, Majidi S. Comparative study of the effect of two different doses of intravenous labetalol on the cardiovascular response to endotracheal extubation. J Cardiovasc Thorac Res. 2023;15:98−105.
36. Sohn J, Chun H, Woo M. Effect of Esmolol on Cardiovascular Responses to Extubation. Korean J Anesthesiol. 1995;28:520−7.
37. Song F, Jin Y, Li P, Zheng C, Zhao X. Effect of Different Concentrations of Esmolol on Perioperative Hemodynamics and Analgesia in Patients Undergoing Colectomy: a Prospective, Randomized Controlled Study. Drug Des Devel Ther. 2021;15:5025−33.
38. Unal Y, Ozsoylar O, Sariguney D, Arslan M, Yardim R. The efficacy of Esmolol to blunt the haemodynamic response to endotracheal extubation in lumbar disc surgery. Res J Med Sci. 2008;2:99−104.
39. Velayutham P, Adhikary S, Job V, et al. Perioperative hypertension associated neurohumoral stress response in craniotomy patients: effects of b-blocker and angiotensin converting enzyme inhibitor. Interdiscip Neurosurg Adv Tech Case Manag. 2020;19. Available from: https://www.cochranelibrary.com/ central/doi/10.1002/central/CN-02009800/full.
40. Yor € uko € glu D, Goktug A, Alano € glu Z, Tulunay M. Comparison of intravenous metoprolol, verapamil and diltiazem on the attenuation of haemodynamic changes associated with tracheal extubation. Eur J Anaesthesiol. 1999;16:462−7.
41. Zeng W, Xu M, Chen B, Jiang Y, Tan H. Effect of esmolol on propofol dose requirement for anesthesia in thyroidectomy. Nan Fang Yi Ke Da Xue Xue Bao. 2007;27(8):1221−3.
42. Zhang X, Hu Q, Chen Q, Wang W. The effect of continuous perfusion of esmolol on cardiovascular risk in elderly patients undergoing noncardiac surgery. Pharm. 2017;72:487−9.
43. Higgins J, Thomas J, Chandler J, et al. Cochrane Handbook for Systematic Reviews of Interventions version 6.4 (updated August 2023) [Internet] Cochrane. 2023. Available from: www. training.cochrane.org/handbook.
44. Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.
45. Sterne JAC, Savovic J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019 Aug 28;366:l4898.
46. Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L. Contourenhanced meta-analysis funnel plots help distinguish publication bias from other causes of asymmetry. J Clin Epidemiol. 2008;61:991−6.
47. Egger M, Davey Smith G, Schneider M, Minder C. Bias in metaanalysis detected by a simple, graphical test. BMJ. 1997;315:629−34.
48. Pustejovsky JE, Rodgers MA. Testing for funnel plot asymmetry of standardized mean differences. Res Synth Methods. 2019;10:57−71.
49. Team RStudio. RStudio: Integrated Development for R. Boston, MA: RStudio, PBC; 2020.
50. Van den Berg AA, Savva D, Honjol NM. Attenuation of the haemodynamic responses to noxious stimuli in patients undergoing cataract surgery. A comparison of magnesium sulphate, esmolol, lignocaine, nitroglycerine and placebo given i.v. with induction of anaesthesia. Eur J Anaesthesiol. 1997;14:134−47.
51. Tung A, Fergusson NA, Ng N, Hu V, Dormuth C, Griesdale DEG. Medications to reduce emergence coughing after general anaesthesia with tracheal intubation: a systematic review and network meta-analysis. Br J Anaesth. 2020;124:480−95.
52. Fallouh HB, Bardswell SC, McLatchie LM, Shattock MJ, Chambers DJ, Kentish JC. Esmolol cardioplegia: the cellular mechanism of diastolic arrest. Cardiovasc Res. 2010;87: 552−60.
53. Tanahashi S, Iida H, Dohi S, Oda A, Osawa Y, Yamaguchi S. Comparative effects of ultra-short-acting beta1-blockers on voltage-gated tetrodotoxin-resistant Na+ channels in rat sensory neurons. Eur J Anaesthesiol. 2009;26:196−200.
54. Canning BJ. Anatomy and neurophysiology of the cough reflex: ACCP evidence-based clinical practice guidelines. Chest. 2006;129(1 Suppl):33S−47S.
55. Lee LY, Pisarri TE. Afferent properties and reflex functions of bronchopulmonary C-fibers. Respir Physiol. 2001;125:47−65.
56. Frishman WH, Murthy S, Strom JA. Ultra-short-acting betaadrenergic blockers. Med Clin North Am. 1988;72:359−72.
57. Davidson A, McKenzie I. Distress at induction: prevention and consequences. Curr Opin Anaesthesiol. 2011;24:301−6.
58. Priel E, Wahab M, Mondal T, et al. The Impact of beta blockade on the cardio-respiratory system and symptoms during exercise. Curr Res Physiol. 2021;4:235−42.
59. Marti HP, Pavía Lopez AA, Schwartzmann P. Safety and tolerabil- ity of b-blockers: importance of cardioselectivity. Curr Med Res Opin. 2024;40(Supp1):55−62.
60. Miller KA, Harkin CP, Bailey PL. Postoperative tracheal extubation. Anesth Analg. 1995;80:149−72.
61. Benham-Hermetz J, Mitchell V. Safe tracheal extubation after general anaesthesia. BJA Educ. 2021;21:446−54.
62. Basali A, Mascha EJ, Kalfas I, Schubert A. Relation between perioperative hypertension and intracranial hemorrhage after craniotomy. Anesthesiology. 2000;93:48−54.
Submetido em:
20/12/2024
Aceito em:
30/06/2025